Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma

Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma

Male gender is a risk factor for mortality in patients with papillary thyroid carcinoma (PTC). This study investigated the impact of androgen receptor (<i>AR</i>) gene expression on the clinical features and progression of PTC. The levels of <i>AR</i> mRNA and protein in froz...

Full description

Bibliographic Details
Main Authors:	Chen-Kai Chou, Shun-Yu Chi, Fong-Fu Chou, Shun-Chen Huang, Jia-He Wang, Chueh-Chen Chen, Hong-Yo Kang
Format:	Article
Language:	English
Published:	MDPI AG 2020-04-01
Series:	Cancers
Subjects:	papillary thyroid carcinoma androgen receptor tumorigenesis sex difference epithelial-mesenchymal transition
Online Access:	https://www.mdpi.com/2072-6694/12/5/1109

Similar Items

Decreased Expression of Estrogen Receptors Is Associated with Tumorigenesis in Papillary Thyroid Carcinoma
by: Chen-Kai Chou, et al.
Published: (2022-01-01)

Microscopic extrathyroid extension in papillary thyroid carcinoma: impact on response to therapy
by: Bernardo Marques, et al.
Published: (2020-03-01)

The influence of extrathyroidal extension in development of metastasis in papillary thyroid cancer
by: Vladimir A. Solodkiy, et al.
Published: (2020-03-01)

A Radiomic Nomogram for the Ultrasound-Based Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma
by: Xian Wang, et al.
Published: (2021-03-01)

Obesity and Overweight Are Associated with Minimal Extrathyroidal Extension, Multifocality and Bilaterality of Papillary Thyroid Cancer
by: Krzysztof Kaliszewski, et al.
Published: (2021-03-01)

Radiomics based on multiparametric MRI for extrathyroidal extension feature prediction in papillary thyroid cancer
by: Ran Wei, et al.
Published: (2021-02-01)

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
by: Doh Young Lee, et al.
Published: (2017-06-01)

Clinical Predictors of Minimal Extrathyroid Invasion of Papillary Thyroid Cancer
by: Pavlo Lishchynskyi, et al.
Published: (2022-06-01)

Three-dimensional ultrasound-based radiomics nomogram for the prediction of extrathyroidal extension features in papillary thyroid cancer
by: Wen-Jie Lu, et al.
Published: (2023-08-01)

The Diagnostic Performance of Ultrasonography in the Evaluation of Extrathyroidal Extension in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
by: Peter P. Issa, et al.
Published: (2022-12-01)

Minimal extrathyroidal extension is associated with lymph node metastasis in single papillary thyroid microcarcinoma: a retrospective analysis of 814 patients
by: Ra-Yeong Song, et al.
Published: (2022-05-01)

Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer
by: Viviana A. Ruiz-Pozo, et al.
Published: (2023-04-01)

Lipase member H is a downstream molecular target of hypoxia inducible factor-1α and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines
by: Li Y, et al.
Published: (2019-01-01)

80MAP17 promotes the tumorigenesis of papillary thyroid carcinoma by reducing the stability of p53
by: Kun Yu, et al.
Published: (2021-10-01)

Identifying the Transcriptional Regulatory Network Associated With Extrathyroidal Extension in Papillary Thyroid Carcinoma by Comprehensive Bioinformatics Analysis
by: Yong Chen, et al.
Published: (2020-05-01)

Papillary Thyroid Carcinoma with Spindle Cell Metaplasia: A Rare Encounter
by: Ka Wen Leong, et al.
Published: (2022-03-01)

Extrathyroidal Extension Prediction of Papillary Thyroid Cancer With Computed Tomography Based Radiomics Nomogram: A Multicenter Study
by: Pengyi Yu, et al.
Published: (2022-06-01)

Clinical Significance of Tumor Size in Gross Extrathyroidal Extension to Strap Muscles (T3b) in Papillary Thyroid Carcinoma: Comparison with T2
by: Joonseon Park, et al.
Published: (2022-09-01)

Retracted: Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma
by: Jiaojiao Ding, et al.
Published: (2021-08-01)

“Micro” Extrathyroidal Extension in Risk Stratification for Papillary Thyroid Carcinoma: Should It Be in the Intermediate-Risk or High-Risk Group? A Single-Center Retrospective Study
by: He Q, et al.
Published: (2022-11-01)

Microscopic extrathyroidal extension does not affect the prognosis of patients with papillary thyroid carcinoma: A propensity score matching analysis
by: Ke-cheng Jiang, et al.
Published: (2024-02-01)

Causal inference between aggressive extrathyroidal extension and survival in papillary thyroid cancer: a propensity score matching and weighting analysis
by: Ming Xu, et al.
Published: (2023-05-01)

CD73 mitigates ZEB1 expression in papillary thyroid carcinoma
by: Samlai Vedovatto, et al.
Published: (2024-02-01)

One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: The first experience in Taiwan
by: Lay San Lim, et al.
Published: (2022-08-01)

Microscopic Extrathyroidal Extension Results in Increased Rate of Tumor Recurrence and Is an Independent Predictor of Patient’s Outcome in Middle Eastern Papillary Thyroid Carcinoma
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021-12-01)

Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter?
by: Hyeji Kim, et al.
Published: (2022-04-01)

Predicting Extrathyroidal Extension in Papillary Thyroid Carcinoma Using a Clinical-Radiomics Nomogram Based on B-Mode and Contrast-Enhanced Ultrasound
by: Liqing Jiang, et al.
Published: (2023-05-01)

Knockdown of LINC02471 Inhibits Papillary Thyroid Carcinoma Cell Invasion and Metastasis by Targeting miR-375
by: Chen D, et al.
Published: (2020-09-01)

The impact of minimal extrathyroidal extension in the recurrence of papillary thyroid cancer patients
by: Maria Fernanda Ozorio de Almeida, et al.
Published: (2020-06-01)

Computed Tomography Radiomic Nomogram for Preoperative Prediction of Extrathyroidal Extension in Papillary Thyroid Carcinoma
by: Bin Chen, et al.
Published: (2019-09-01)

PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer
by: Wan-Lin Liu, et al.
Published: (2021-11-01)

Aberrant intrathyroidal lymph node metastasis in classical papillary thyroid carcinoma
by: Wan Mohd Nazlee Wan Zainon, et al.
Published: (2021-09-01)

<i>ABCA1</i>-Mediated EMT Promotes Papillary Thyroid Cancer Malignancy through the ERK/Fra-1/ZEB1 Pathway
by: Ji-Hye Park, et al.
Published: (2023-01-01)

Is Gross Extrathyroidal Extension to Strap Muscles (T3b) Only a Risk Factor for Recurrence in Papillary Thyroid Carcinoma? A Propensity Score Matching Study
by: Yongseon Kim, et al.
Published: (2022-05-01)

Ultrasonographic imaging of papillary thyroid carcinoma variants
by: Jung Hee Shin
Published: (2017-04-01)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
by: Jia-Feng Chen, et al.
Published: (2019-10-01)

Quercetin induces proteolysis of mesenchymal marker vimentin through activation of caspase-3, and decreases cancer stem cell population in human papillary thyroid cancer cell line.
by: Devavrat Tripathi, et al.
Published: (2021-11-01)

Occult Metastatic Papillary Thyroid Cancer in an Adolescent
by: Anna Chin, MD, MPH, et al.
Published: (2024-01-01)

Our experience with papillary thyroid microcancer
by: Anulekha Mary John, et al.
Published: (2014-01-01)

Hashimoto’s Thyroiditis and the Risk of Papillary Thyroid Cancer in Children
by: Jean-Nicolas Gallant, et al.
Published: (2023-10-01)